This was the stock's third consecutive day of losses.

Mairs & Power, an investment advisor, released the “Mairs & Power Balanced Fund” first quarter 2025 investor letter. A copy ...

We recently published a list of Jim Cramer Talked About These 7 Stocks Recently. In this article, we are going to take a look ...

Diamond Hill Capital, an investment management company, released its “Large Cap Fund” first-quarter 2025 investor letter. A ...

The court is still scheduled to hear three other bellwether cases about the issue, with the next trial slated to begin in ...

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at ...

Abbott Laboratories is “well positioned” to handle tariffs, CEO and Chairman Robert Ford said during a call with investors ...

Abbott Laboratories shares surged Wednesday after the medical device maker said it plans to invest $500 million in U.S. operations and topped Wall Street’s expectations with its first-quarter results.

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Abbott ...

Abbott Lab’s stock bucks a broad market selloff, after quarterly profit extends a long streak of beats on the back of strong demand for diabetes products.

Two claims in a whistleblower suit alleging that Abbott Laboratories Inc. and others improperly billed the government for ...

A judge threw out one the first "bellwether" federal lawsuits against Abbott Laboratories and its competitor, Mead Johnson, ...